What is the primary use of Wegovy (semaglutide)?

Wegovy (semaglutide) is primarily used for weight loss. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been specifically approved by regulatory agencies for chronic weight management in adults with obesity or overweight conditions accompanied by weight-related comorbidities. Unlike its cousin, semaglutide is also indicated for diabetes management under a different brand name (Ozempic), the focus of Wegovy is on its efficacy in promoting weight loss.

Clinical studies have shown that individuals using Wegovy, in combination with a reduced-calorie diet and increased physical activity, experience significant weight reduction compared to those not using the medication. This medication works by regulating appetite and calorie intake, making it a valuable tool for those struggling with obesity.

Other options, while relevant to the broader category of medications, do not reflect Wegovy's primary indication. For instance, diabetes management doesn't encompass the specific weight-loss characteristics of Wegovy, and hypertension control and cholesterol lowering are not indications associated with this particular medication.